corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 12373

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Germany: Regulator Issues Pharma Fines
Namnews 2008 Jan 11
http://www.kamcity.com/namnews/asp/newsarticle.asp?newsid=38392


Full text:

The German cartel office has issued total fines of E465,000 to various bodies in the country’s pharmaceutical industry, after finding the guilty of holding price agreements following the abolition of price-fixing on non-prescription medication in 2004, in a bid to reduce competition over prices.

The office fined the German association for medicine producers, five pharmaceutical companies, nine regional chemists’ associations and eight drugstores from Hildesheim. The companies affected include Bayer Vital and Boehringer Ingelheim. The regulator said price-fixing talks were held in 24 German cities, which called for the sector to propose that drugstores avoid competition over prices and stick to manufacturers’ price recommendations.

The office said that the fine levied is sufficient, as the price agreements were held several years ago when competition within the sector was first opening up. It said it assumes that such action will not be repeated again.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.